These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1112 related items for PubMed ID: 9795371

  • 1. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM, Jehle DR, Mohan S, Böhm BO.
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM, Ostertag A, Schulten K, Schulz W, Jehle DR, Stracke S, Fiedler R, Deuber HJ, Keller F, Boehm BO, Baylink DJ, Mohan S.
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [Abstract] [Full Text] [Related]

  • 3. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T, Kanatani M, Yamauchi M, Kaji H, Sugishita T, Baylink DJ, Mohan S, Chihara K, Sugimoto T.
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [Abstract] [Full Text] [Related]

  • 4. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME, Spaggiari C, Ziveri MA, Volta C, Federico G, Baroncelli GI, Bernasconi S, Saggese G.
    Horm Res; 2006 Jan; 66(4):162-8. PubMed ID: 16804317
    [Abstract] [Full Text] [Related]

  • 5. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ.
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients.
    Małyszko J, Wołczyński S, Zbroch E, Brzósko S, Małyszko J, Myśliwiec M.
    Nephron; 2002 Mar; 90(3):282-9. PubMed ID: 11867949
    [Abstract] [Full Text] [Related]

  • 7. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
    Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG.
    J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
    [Abstract] [Full Text] [Related]

  • 8. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
    Kim JG, Shin CS, Choi YM, Moon SY, Kim SY, Lee JY.
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
    [Abstract] [Full Text] [Related]

  • 9. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes.
    Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H.
    Diabetes Metab Res Rev; 1999 Sep; 15(5):314-22. PubMed ID: 10585616
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factor-I and bone mineral density.
    Collins D, Woods A, Herd R, Blake G, Fogelman I, Wheeler M, Swaminathan R.
    Bone; 1998 Jul; 23(1):13-6. PubMed ID: 9662125
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
    Spagnoli A, Chiarelli F, Vorwerk P, Boscherini B, Rosenfeld RG.
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
    Thorén M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Sääf M, Baylink DJ, Mohan S.
    J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
    [Abstract] [Full Text] [Related]

  • 13. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M, Fukunaga M, Ohtawa T, Harada T.
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [Abstract] [Full Text] [Related]

  • 14. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S, Riggs BL, Melton LJ, Achenbach SJ, Atkinson EJ, Khosla S.
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [Abstract] [Full Text] [Related]

  • 15. Relationships of serum levels of insulinlike growth factors with indices of bone metabolism and nutritional conditions in hemodialysis patients.
    Nanba K, Nagake Y, Miyatake N, Nakao K, Akagi S, Sugimoto T, Yamasaki H, Oishi K, Ichikawa H, Makino H.
    Nephron; 2001 Oct; 89(2):145-52. PubMed ID: 11549896
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone-binding protein related immunoreactivity is regulated by the degree of insulinopenia in diabetes mellitus.
    Kratzsch J, Keliner K, Zilkens T, Schmidt-Gayk H, Selisko T, Scholz GH.
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):673-8. PubMed ID: 8759179
    [Abstract] [Full Text] [Related]

  • 17. Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa.
    Audí L, Vargas DM, Gussinyé M, Yeste D, Martí G, Carrascosa A.
    Pediatr Res; 2002 Apr; 51(4):497-504. PubMed ID: 11919336
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
    Szulc P, Joly-Pharaboz MO, Marchand F, Delmas PD.
    Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.
    Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyfan-Hughes S, Holly JM, Yudkin JS.
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):221-8. PubMed ID: 10396366
    [Abstract] [Full Text] [Related]

  • 20. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T, Nishiyama K, Kuribayashi F, Chihara K.
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.